Abstract 1612: Molecular analysis of clinically actionable gene alterations in clear cell carcinoma of the ovary using next-generation sequencing and immunohistochemical CNV analysis
Hiroshi Asano(Hokkaido University), Noriaki Sakuragi(Hokkaido University), Kanako C. Hatanaka(Hokkaido University Hospital), Ayako Nozaki(Hokkaido University), Hidemichi Watari(Hokkaido University of Science), Yosuke Konno(Hokkaido University of Science), Asami Okumura(Hokkaido University Hospital), Yoshihiro Matsuno(Hokkaido University Hospital), Toraji Amano(Hokkaido University Hospital), Kei Ihira(Hokkaido University), Yutaka Hatanaka(Hokkaido University), Daisuke Endo(Kishokai Medical Corporation), Tatsuya Kato(Hokkaido University), Takashi Mitamura(Sapporo University)
Cited by 0
Related Papers
Apoptosis and Molecular Targeting Therapy in Cancer
|BioMed Research International|2014|1.1k
High-capacity electrode materials for rechargeable lithium batteries: Li <sub>3</sub> NbO <sub>4</sub> -based system with cation-disordered rocksalt structure
|Proceedings of the National Academy of Sciences|2015|486
Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis
|Oncogene|2012|305
Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter Study
|Journal of Thoracic Oncology|2016|273